New research suggests that an enzyme called SNRK suppresses inflammation in obesity-related “white fat” while increasing metabolism in heat-producing “brown fat.”
Genomics will change what patients expect from their provider, as well as change how physicians treat them. Before this happens, education on both sides is needed. This month we look at some of the big talking points.
23andMe’s ancestry tests and those from three other companies produce drastically different results, according to Kristen Brown, writing for Gizmodo.
The good thing about J.P. Morgan Week is that it draws innovative people who want to invest. The question is, should healthcare capital be focused on solving big problems and getting rewarded for them, or just focused on the status quo?
Two new cancer treatments have shown miraculous cures, but if you happen to live in a handful of rural states in the U.S. (let alone outside the U.S.) — you’ll have to travel hundreds of miles to get them. And it’s by no means certain that they’ll eventually be available everywhere.
“My Greatest Achievement Has Been Overcoming My Own Shyness to Advocate My Disabled Child” – Judith Sheppard
Judith Sheppard is the parent of a 22-year-old young man with FOXG1 Syndrome. We’ve had a chat with her before her talk “Finding the Needle in the Haystack” at the Festival of Genomics in London 2018.
Seizures and mood disorders such as depression may share the same genetic cause in some people with epilepsy, a new study suggests.
As a part of an effort to understand what health issues might be particular to people in the Nevada region, The Healthy Nevada Project is planning to sequence the DNA of 40,000 Nevadans.
When deprived of sleep, some people are able to cope and respond much better than others. Why is that?
How consumer genetic testing companies actually use your DNA is often less than clear and made more opaque through legal jargon and vagaries.
Biologists have developed a method for rapidly screening hundreds of thousands of potential drugs for fighting infections, an innovation that holds promise for combating the growing scourge of antibiotic-resistant bacteria.
Roche Diagnostics and GE Healthcare have announced a collaboration aimed at developing a digital diagnostics platform providing clinical decision platform to support precision medicine.
In a new study, melanoma patients who received immunotherapy while taking a specific type of beta blocker lived longer than patients who received immunotherapy alone, researchers report.
It has been widely reported that bacteria will evolve to render antibiotics mostly ineffective by mid-century—and current strategies to make up for the projected shortfalls haven’t worked.
When a hepatitis C treatment called Harvoni was released in 2014, Dr. Ronald Cirillo knew it was a big deal.